Allianz Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Allianz Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-112,011	Closed	-$3.81M	–	2727
2021 Q3	$3.81M	Sell	112,011 -3,448	-3%	-$110K	﹤0.01%	1389
2021 Q2	$4.23M	Sell	115,459 -4,182	-3%	-$162K	﹤0.01%	1193
2021 Q1	$5.37M	Buy	119,641 +25,225	+27%	+$1.17M	0.01%	1035
2020 Q4	$5.39M	Buy	94,416 +11,664	+14%	+$691K	0.01%	1019
2020 Q3	$4.25M	Sell	82,752 -5,949	-7%	-$291K	﹤0.01%	1038
2020 Q2	$5.3M	Buy	88,701 +6,012	+7%	+$322K	0.01%	1187
2020 Q1	$3.4M	Buy	82,689 +28,978	+54%	+$1.61M	﹤0.01%	1327
2019 Q4	$3.34M	Buy	53,711 +37,771	+237%	+$1.8M	﹤0.01%	1664
2019 Q3	$534K	Sell	15,940 -651	-4%	-$19.3K	﹤0.01%	2352
2019 Q2	$374K	Buy	+16,591	New	+$388K	﹤0.01%	2441

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Allianz Asset Management's DCPH Position: Q4 2021 in Review

Allianz Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 112,011 shares — an estimated $3.81M sold.

Allianz Asset Management first reported a position in DCPH in Q2 2019 and held it in 10 quarters. The position peaked at $5.39M in Q4 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

Allianz Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Allianz Asset Management sold 112,011 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $3.81M.
Allianz Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 10 quarters.
Allianz Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $5.39M in Q4 2020.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Allianz Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.